PULSE BIOSCIENCES, INC.
PLSENasdaq
$28.68
↑ +4.7%Jul 17 close · end-of-day
Price
1Y↑ +82.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
—
Enterprise Value
—
P/E
—
P/S
—
P/B
—
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$751,000.00
Net Income (TTM)
-$74.6M
Free Cash Flow (TTM)
-$55.5M
Gross Margin
—
Operating Margin
-10392.1%
Net Margin
-9929.0%
ROE
-112.5%
ROIC
—
Debt / Equity
—
Net Cash
$68.3M
Return 1Y
+83.3%
Company profile
Management & directors
- Laviolette Paul AChief Executive Officer
- Danahy Kevin PatrickChief Commercial Officer
- Uecker DarrinChief Technology Officer
Roles derived from SEC Form 4 filings.
Earnings
PLSE Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$401,000.00—
Diluted EPS——
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $1.4M | $700,000.00 | $0.00 | $0.00 | $350,000.00 |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$50.0M | -$63.0M | -$58.1M | -$43.6M | -$56.3M | -$76.9M |
| Net income | -$49.9M | -$63.7M | -$58.5M | -$42.2M | -$53.6M | -$72.8M |
| Diluted EPS | — | — | — | — | — | — |
| Operating cash flow | -$35.4M | -$54.1M | -$47.0M | -$33.0M | -$36.3M | -$54.1M |
| Free cash flow | -$35.8M | -$54.5M | -$47.4M | -$33.2M | -$36.5M | -$54.4M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | -4443.9% | -8293.9% | — | — | -21982.6% |
| Net margin | — | -4489.4% | -8357.9% | — | — | -20794.6% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $86,000.00 | $264,000.00 | $401,000.00 |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$11.7M | -$13.7M | -$20.3M | -$18.0M | -$20.3M | -$20.4M | -$18.3M | -$19.1M |
| Net income | -$11.4M | -$12.7M | -$19.4M | -$16.8M | -$19.2M | -$19.4M | -$17.4M | -$18.6M |
| Diluted EPS | — | — | — | — | — | — | — | — |
| Operating cash flow | -$8.4M | -$9.0M | -$9.1M | -$13.5M | -$12.8M | -$13.0M | -$14.8M | -$14.6M |
| Free cash flow | -$8.4M | -$9.1M | -$9.2M | -$13.6M | -$12.9M | -$13.1M | -$14.9M | -$14.6M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | -23682.6% | -6914.0% | -4775.6% |
| Net margin | — | — | — | — | — | -22540.7% | -6603.4% | -4633.7% |
Company news
Coming soonHeadlines for PLSE will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-11 | DUGGAN ROBERT W | Buy | 660,233 | $19.69 | $13.0M | filing |
| 2026-05-11 | DUGGAN ROBERT W | Buy | 660,233 | $19.69 | $13.0M | filing |
| 2026-05-11 | LAVIOLETTE PAUL A· Chief Executive Officer | Buy | 15,000 | $19.69 | $295,350.00 | filing |
| 2026-05-11 | LAVIOLETTE PAUL A· Chief Executive Officer | Buy | 15,000 | $19.69 | $295,350.00 | filing |
| 2026-02-18 | Danahy Kevin Patrick· Chief Commercial Officer | Sale | 5,000 | $23.64 | $118,200.00 | filing |
| 2026-02-18 | Danahy Kevin Patrick· Chief Commercial Officer | Option exercise | 5,000 | $1.53 | $7,650.00 | filing |
| 2026-02-17 | Danahy Kevin Patrick· Chief Commercial Officer | Sale | 20,000 | $23.63 | $472,600.00 | filing |
| 2026-02-17 | Danahy Kevin Patrick· Chief Commercial Officer | Option exercise | 20,000 | $1.53 | $30,600.00 | filing |
| 2026-02-13 | Danahy Kevin Patrick· Chief Commercial Officer | Sale | 20,000 | $23.53 | $470,600.00 | filing |
| 2026-02-13 | Danahy Kevin Patrick· Chief Commercial Officer | Option exercise | 20,000 | $1.53 | $30,600.00 | filing |
| 2026-02-12 | Danahy Kevin Patrick· Chief Commercial Officer | Sale | 20,000 | $23.37 | $467,400.00 | filing |
| 2026-02-12 | Danahy Kevin Patrick· Chief Commercial Officer | Option exercise | 20,000 | $1.53 | $30,600.00 | filing |
| 2026-02-11 | Danahy Kevin Patrick· Chief Commercial Officer | Sale | 20,000 | $25.20 | $504,000.00 | filing |
| 2026-02-11 | Danahy Kevin Patrick· Chief Commercial Officer | Option exercise | 20,000 | $1.53 | $30,600.00 | filing |
| 2026-02-10 | Danahy Kevin Patrick· Chief Commercial Officer | Sale | 20,000 | $23.52 | $470,400.00 | filing |
| 2026-02-10 | Danahy Kevin Patrick· Chief Commercial Officer | Option exercise | 20,000 | $1.53 | $30,600.00 | filing |
| 2026-02-09 | Danahy Kevin Patrick· Chief Commercial Officer | Sale | 20,000 | $21.45 | $429,000.00 | filing |
| 2026-02-09 | Danahy Kevin Patrick· Chief Commercial Officer | Option exercise | 20,000 | $1.53 | $30,600.00 | filing |
| 2025-10-02 | Danahy Kevin Patrick· Chief Commercial Officer | Sale | 4,600 | $18.53 | $85,238.00 | filing |
| 2025-10-02 | Danahy Kevin Patrick· Chief Commercial Officer | Option exercise | 4,600 | $1.53 | $7,038.00 | filing |
| 2025-09-19 | Danahy Kevin Patrick· Chief Commercial Officer | Sale | 400 | $18.48 | $7,392.00 | filing |
| 2025-09-19 | Danahy Kevin Patrick· Chief Commercial Officer | Option exercise | 400 | $1.53 | $612.00 | filing |
| 2025-09-18 | Danahy Kevin Patrick· Chief Commercial Officer | Sale | 20,000 | $18.49 | $369,800.00 | filing |
| 2025-09-18 | Danahy Kevin Patrick· Chief Commercial Officer | Option exercise | 20,000 | $1.53 | $30,600.00 | filing |
| 2025-09-17 | UECKER DARRIN· Chief Technology Officer | Option exercise | 100,000 | $4.00 | $400,000.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.